Name | Position | Country | Term | Time in Office |
Tricia Ravalico | Chair/ABBOTT | US | 1st | 2021 01 - 2023 12 |
Alessandro Ortisi | Secretary/SIEMENS Healthineers | IT | 1st | 2021 04 - 2023 12 |
Jean-Sébastien Blanchet | Member/BECKMAN COULTER | FR | 2nd | 2022 01 - 2024 12 |
Vincent Chen | Member/SNIBE | CN | 1st | 2021 04 - 2023 12 |
Brendan Meyer | Member/BECTON DICKINSON | UK | 1st | 2021 04 - 2023 12 |
Andy Quintenz | Member/BIO-RAD | US | 1st | 2022 04 - 2024 12 |
Joseph Passarelli | EB Corporate Representative/ROCHE | US | 1st | 2021 01 - 2023 12 |
TF-CM Meeting in person in Munich at the EuroMedLab Congress
April 11 2022
From left to right - top to bottom:
Michael Rottmann - SD Corporate Member Rep/Roche; Tricia Ravalico - Chair/Abbott; Alessandro Ortisi - Secretary/Siemens Healthineers; Joseph Passarelli - Executive Board Corporate Member Rep/Roche - Jean-Sébastien Blanchet - Member/Beckman Coulter.
The aim of IFCC TF-CM is to enable Corporate Members to make significant and growing contributions to the activities of IFCC, and to elevate key topics and priorities for the betterment of industry collaborations, laboratory medicine and health care.
The TF-CM will report directly to the IFCC Executive Board. The Corporate Representative of the Executive Board will be a liaison to the EB while serving as a member of TF-CM. The TF-CM will prepare reports to the Executive Board on meeting outcomes.
The IFCC Task Force Corporate Members (TF-CM) was approved by the IFCC Executive Board and established in 2019 in order to strengthen the collaboration between IFCC and its Corporate Members. Similar to other task forces, the TF-CM reports directly to the IFCC Executive Board. The TF-CM consists of the chair and 6 other members, including the secretary, the Corporate Representative at the IFCC Executive Board, and 3 other members. Members are elected by the IFCC EB from nominations from the corporate representatives. The corporate representatives from each of the other divisions are also invited and encouraged to attend the TF-CM meetings. Memberships on the TF-CM are for 3 years with the possibility of extension for an additional 3 years.
Read the TF-CM article extracted from the IFCC e-News-March 2021
Name | Company |
Jan Gorka | DiaSys Diagnostic Systems |
Gavin Tu | Maccura Biotechnology |
Yan Liu | Mindray |
Nadav Kaufman | Ortho Clinical Diagnostics |
Anne Skurup | Radiometer Medical ApS |
Maurizio Gramegna | Technogenetics |
Tricia RAVALICO
Director, Scientific Leadership and Education
Medical and Scientific Affairs
Core Diagnostics
Abbott
100 Abbott Park Road
CP-01-5
Abbott Park, IL 60064
USA
e-mail: Tricia.Ravalico@abbott.com
Alessandro ORTISI
Associate Director / Global Clinical Marketing
Laboratory Diagnostics
SHS LD M&S CLS CM CA
Siemens Healthineers
Via Vipiteno, 4
20128 Milano
Italy
e-mail: alessandro.ortisi@siemens-healthineers.com
Jean-Sébastien BLANCHET
Beckman Coulter Diagnostics
Director Medical and Scientific
France
e-mail: jblanchet@beckman.com
Vincent CHEN
Global Marketing Manager
SNIBE
No.23, Jinxiu East Road
Pingshan District
518122 Shenzhen
P.R. China
e-mail: vincent.chen@snibe.com
Brendan MEYER
Senior Manager, Medical Affairs Europe
Integrated Diagnostic Solutions
Becton Dickinson Life Sciences
Winnersh
UK
e-mail: Brendan.Meyer@bd.com
T. Andrew QUINTENZ
Bio-Rad Laboratories
Assoc Director, Quality Systems Market Development
Clinical Diagnostics Group
9500 Jeronimo Road
Irvine CA 92618-2017
USA
e-mail: andy_quintenz@bio-rad.com
Joseph PASSARELLI
Scientific Relations, Research and Development
Roche Diagnostics Corporation
9115 Hague Road, PO Box 50416
Indianapolis, Indiana 46250-0416 - USA
Tel: +1 317 521 4206
Fax: +1 317 521 2324
Mobile: +1-317-625-7810
E-mail: joseph.passarelli@roche.com